Marina Gilli
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.
Journal: Journal of clinical medicine
Published: November 23, 2025
Predictive role of functional respiratory tests in LUng toxicity in stage III NSCLC treated with chemo-, raDIO- and immuno-therapy: PRELUDIO TRIAL.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 10, 2025
Performance of Control Arms in Trials Leading to FDA Cancer Drug Approvals.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 20, 2025
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 09, 2025
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results.
Journal: Clinical lung cancer
Published: January 27, 2025
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Journal: Frontiers in immunology
Published: September 05, 2023
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
Journal: The oncologist
Published: July 18, 2023
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.
Journal: Cancers
Published: October 25, 2022
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report.
Journal: Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace
Published: September 27, 2022
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Journal: Translational cancer research
Published: November 28, 2018
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report.
Journal: Journal of cardiothoracic surgery
Published: November 19, 2018
Last Updated: 09/26/2026